Source: Annual Congress 2006 - Taormina 4th ERS Lung Science Conference "hypoxia in lung biology and disease"
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
W. Kummer (Giessen, Germany). Hypoxic vasoconstriction of partial muscular intra-acinar pulmonary arteries in the mouse. Annual Congress 2006 - Taormina 4th ERS Lung Science Conference "hypoxia in lung biology and disease"

Member's Comments

No comment yet.

Related content which might interest you: Dag-dependent regulation of trpc6 in hypoxic pulmonary vasoconstriction Source: Annual Congress 2009 - Pathobiology of pulmonary vascular diseases Year: 2009 Involvement of pulmonary artery smooth muscle cell apoptosis in simvastatin-induced regression of hypoxic pulmonary hypertension Source: Annual Congress 2008 - Pathophysiology of pulmonary hypertension Year: 2008 Effects of Sildenafil on hypoxic pulmonary vasoconstriction in dogs Source: Eur Respir J 2001; 18: Suppl. 33, 490s Year: 2001 Hypoxia-induced pulmonary edema Source: Lung Science Conference 2006 - Hypoxia in Lung Biology and Disease Year: 2006 SuHx rat model: partly reversible pulmonary hypertension and progressive intima obstruction Source: Eur Respir J 2014; 44: 160-168 Year: 2014 Effect of normobaric hypoxia on pulmonary hemodynamics in patients with precapillary pulmonary hypertension Source: International Congress 2017 – Exercise and physiology in pulmonary hypertension Year: 2017 Pulmonary vein banding-induced pulmonary venous congestion causes pulmonary hypertension in rats. Source: Virtual Congress 2021 – Pathogenesis and pathophysiology of pulmonary hypertension Year: 2021 Spatial redistribution of pulmonary blood flow by hypoxic pulmonary vasoconstriction in vivo Source: Eur Respir J 2001; 18: Suppl. 33, 415s Year: 2001 CD163 is expressed and modulated in human pulmonary artery smooth muscle cells: Implications for pulmonary artery hypertension Source: International Congress 2015 – Pulmonary hypertension: promising small molecules Year: 2015 Targeting TMEM16A to reverse vasoconstriction and remodelling in idiopathic pulmonary arterial hypertension Source: Eur Respir J, 53 (6) 1800965; 10.1183/13993003.00965-2018 Year: 2019 Comparison of current therapies against endothelin-induced growth in pulmonary smooth arterial muscle cells (PASMCs) derived from patients with pulmonary arterial hypertension Source: International Congress 2014 – Pulmonary hypertension: novel targets and drugs Year: 2014 Role of endothelial and smooth muscle cells in vascular wall remodeling of large pulmonary arteries in patients with CTEPH Source: Annual Congress 2007 - Venous thromboembolic disease Year: 2007 Hypoxic pulmonary vasoconstriction is heterogeneously distributed in the supine pig Source: Eur Respir J 2003; 22: Suppl. 45, 270s Year: 2003 Serotonin-induced smooth muscle hyperplasia in various forms of human pulmonary hypertension Source: Eur Respir J 2004; 24: Suppl. 48, 435s Year: 2004 Peripheral and respiratory muscle strength in pulmonary artery hypertension Source: Annual Congress 2012 - Assessment of physical activity, exercise, muscle function and clinical characteristics as outcomes in physiotherapy and rehabilitation Year: 2012 Hypoxic pulmonary vasoconstriction in COPD-associated pulmonary hypertension: been there, done that? Source: Eur Respir J, 50 (1) 1701191; 10.1183/13993003.01191-2017 Year: 2017 IL-6 receptor overexpression in pulmonary arterial smooth muscle cells in idiopathic pulmonary hypertension Source: International Congress 2015 – Pulmonary hypertension: novel insights into the biology of the disease Year: 2015 PDGF promotes pulmonary artery smooth muscle cell proliferation and migration in pulmonary arterial hypertension Source: Annual Congress 2006 - Signalisation in the pulmonary vasculature: new pathways and wrong signals Year: 2006